Seligmann, J., Morton, D., Seymour, M. et al. (11 more authors) (2023) 552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel. In: Annals of Oncology. ESMO Congress 2023, 2023-10-20 2023-10-24, Madrid, Spain. Elsevier , S412-S412.
Metadata
Item Type: | Proceedings Paper |
---|---|
Authors/Creators: |
|
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Pathology and Data Analytics The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology |
Funding Information: | Funder Grant number Yorkshire Cancer Research Account Ref: 2UOLEEDS L386-RA/2015/R2/003 Cancer Research UK Supplier No: 138573 RCCCTF-Nov21\100001 |
Depositing User: | Symplectic Publications |
Date Deposited: | 20 Dec 2023 10:10 |
Last Modified: | 20 Dec 2023 10:10 |
Status: | Published |
Publisher: | Elsevier |
Identification Number: | 10.1016/j.annonc.2023.09.1743 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:206795 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online